The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: The northern New England experience

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1471-1480

  Malenka, David J ^a,b   McGrath, Paul D ^b,c   Wennberg, David E ^b,c   Ryan Jr , Thomas J ^c   Kellett Jr, Mirle A ^c   Shubrooks Jr , Samuel J ^d   Bradley, William A ^e   Hettlemen, Bruce D ^a   Robb, John F ^a   Hearne, Michael J ^e   Silver, Theodore M ^f   Watkins, Matthew W ^g   O'Meara, John R ^c   VerLee, Peter N ^f   O'Rourke, Daniel J ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c MAINE MEDICAL CENTER   (United States)

^d CATHOLIC MEDICAL CENTER   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f EASTERN MAINE MEDICAL CENTER   (United States)

^g FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA BALLOON; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MINIMAL RESIDUAL DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SURGEON; SURGICAL MORTALITY; TREATMENT OUTCOME; UNITED STATES;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL COMPETENCE; CORONARY ARTERY BYPASS; CORONARY DISEASE; HUMANS; LOGISTIC MODELS; NEW ENGLAND; QUALITY OF HEALTH CARE; STENTS; TREATMENT OUTCOME;

EID: 0033231147     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00393-9     Document Type: Article

References (36)

1. Bon Tempo C.P., Sherber H.S., Sheridan M. Relation of low, moderate, high volume PTCA operations and outcomes. (abstr) Cathet Cardiovasc Diagn. 35:1995;79.
2. Kimmel S.E., Berlin J.A., Laskey W.K. The relationship between coronary angioplasty procedure volume and major complications. JAMA. 274:1995;1137-1142.
3. Shook T.L., Sun G.W., Burstein S., Eisenhauer A.C., Matthews R.V. Comparison of percutaneous transluminal coronary angioplasty outcome and hospital costs for low-volume and high-volume operators. Am J Cardiol. 77:1996;331-336.
4. O'Neill W.W., Griffin J.J., Stone G., et al. Operator and institutional volume do not affect the procedural outcome of primary angioplasty therapy. (abstr) J Am Coll Cardiol. 27:(Suppl A):1996;13A.
5. Jollis J.G., Peterson E.D., Nelson C.L., et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation. 96:1997;2485-2491.
6. Hannan E.L., Racz M., Ryan T.J., et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA. 279:1997;892-898.
7. Ellis S.G., Weintraub W., Holmes D., Shaw R., Block P.C., King S.B. III. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 96:1997;2479-2484.
8. Klein L.W., Schaer G.L., Calvin J.E., et al. Does low individual operator coronary interventional procedural volume correlate with worse institutional procedural outcome? J Am Coll Cardiol. 30:1997;870-877.
9. McGrath P.D., Wennberg D.E., Malenka D.J., et al. Operator volume and outcomes in 12,988 percutaneous coronary interventions. J Am Coll Cardiol. 31:1998;570-576.
10. GUSTO (IIb) Angioplasty Substudy Group . The global use of strategies to open occluded coronary arteries in acute coronary syndromes a clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction . N Engl J Med. 336:1997;1621-1628.
11. Jollis J.G., Peterson E.D., DeLong E.R., et al. The relation between the volume of coronary angioplasty procedures at hospitals treating medi-care beneficiaries and short-term mortality. N Engl J Med. 331:1994;1625-1629.
12. Kato N.S., Carter G.M. Volume-mortality tradeoff for percutaneous transluminal coronary angioplasty in the United States. (abstr) J Am Coll Cardiol. 27:(Suppl A):1996;13A.
13. Tiefenbrunn A.J., Chandra N.C., French W.J., Gore J.M., Rogers W.J. Clinical experience with primary PTCA compared with alteplase (rt-PA) in patients with acute myocardial infarction a report from the Second National Registry of Myocardial Infarction (NRMI 2) . J Am Coll Cardiol. 31:1998;1240-1245.
14. Zahn R., Vogt A., Neuhaus K.L., Schuster S., Senges J. Angioplasty in acute myocardial infarction in clinical practice results in 4,625 patients from the ALKK Angioplasty Registry . [abstr] J Am Coll Cardiol. 29:(Suppl A):1997;15A.
15. Hirshfeld J.W. Jr, Ellis S.G., Faxon D.F., et al. Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures. Statment of the American College of Cardiology. J Am Coll Cardiol. 31:1998;722-743.
16. Roubin G.S., Cannon A.D., Agrawal S.K., et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 85:1992;916-927.
17. Lincoff A.M., Topol E.J., Chapekis A.T., et al. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty a matched case-control study . J Am Coll Cardiol. 21:1993;866-875.
18. Herrmann H.C., Buchbinder M., Clemen M.W., et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation. 86:1992;812-819.
19. George B.S., Noorhees W.D., Roubin G.S., et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty clinical and angiographic outcomes . J Am Coll Cardiol. 22:1993;135-143.
20. de Muinck E.D., den Jeijer P., van Dijk R.B., et al. Autoperfusion balloon versus stent for acute or threatened closure during percutaneous transluminal coronary angioplasty. Am J Cardiol. 74:1994;1002-1005.
21. Northern New England Cardiovascular Disease Study Group , Malenka D.J. Indications, practice and procedural outcomes of percutaneous transluminal coronary angioplasty in northern New England in the early 1990s. Am J Cardiol. 78:1996;260-265.
22. O'Connor G.T., Plume S.K., Olmstead E.M., et al. Results of a regional prospective study to improve the in-hospital mortality associated with coronary artery bypass grafting. JAMA. 275:1996;841-846.
23. Principal Investigators of CASS and Their Associates . National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. Circulation. 63:1981;I1-I17.
24. Ryan T.J., Bauman W.B., Kennedy J.W., et al. Guidelines for percutaneous transluminal coronary angioplasty a report of the Americal College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) . J Am Coll Cardiol. 22:1993;2033-2054.
25. Statistical Analysis System (SAS). 1986;SAS Institute Inc, Cary, NC.
26. StataCorp. Stata Statistical Software Release 5.0 . 1997;Stata Corporation, College Station, TX.
27. Kleinbaum D.G., Kupper L.L., Morgenstern H. Epidemiologic Research Principles and Quantitative Methods . 1982;Wadsworth, Belmont, CA.
28. Northern New England Cardiovascular Disease Study Group , O'Connor G.T., Malenka D.J., Levy D.G., Disch D.L., Quinton H.B. Multivariate prediction of adverse outcomes associated with percutaneous transluminal coronary angioplasty. Circulation. 88:1993;I-300.
29. Kahn H.A., Sempas C.T. Statistical Methods in Epidemiology. 1989;Oxford University Press, New York.
30. Malenka D.J., O'Connor G.T. The Northern New England Cardiovascular Disease Study Group a regional collaborative effort for CQI . Joint Commision Journal on Quality Improvement. 21:1995;627-633.
31. Malenka D.J., O'Rourke D., Miller M.A., et al. Cause of death in 12,232 consecutive percutaneous transluminal coronary angioplasties. Am Heart J. 137:1999;632-638.
32. de Muinck E.D., den Heijer P., van Dijk R.B., et al. Autoperfusion balloon versus stent for acute or threatened closure during percutaneous transluminal coronary angioplasty. Am J Cardiol. 74:1994;1002-1005.
33. Lincoff A.M., Topol E.J., Chapekis A.T., et al. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty a matched case-control study . J Am Coll Cardiol. 21:1993;866-875.
34. Roubin G.S., Cannon A.D., Agrawal S.K., et al. Intracoronary stenting for acute and threatened closure complicating percutaneous translu-minal coronary angioplasty. Circulation. 85:1992;916-927.
35. Stent Restenosis Study Investigators , Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
36. Pilote L., Califf R.M., Sapp S., et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 333:1995;565-572.